- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02136758
Cardiovascular Risk Clinic (CRC)
Study Overview
Status
Intervention / Treatment
Detailed Description
The main hypothesis to be tested in the Cardiovascular Risk Clinic was: Can individualized therapeutic lifestyle plans in conjunction with molecular analysis lead to informative assessments of disease risk that can reduce risk factors for diabetes and cardiovascular disease.
Our main objectives were:
A. To investigate the effect of lifestyle modification on: (1) physiological measurements of coronary artery disease (CAD) including carotid intima-media thickness (CIMT), exercise stress tests, blood pressure, body mass index (BMI), and weight; (2) plasma markers associated with development of CAD such as lipids and triglycerides; and (3) molecular characteristics such as gene expression signatures and protein profiles.
B. To determine if patients with heart disease or risk factors that would promote heart disease can achieve and adhere to the goals of a lifestyle change program in a non-residential, out-patient setting.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Pennsylvania
-
Windber, Pennsylvania, United States, 15963
- Windber Research Institute
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria: at least one known risk factor for cardiovascular disease:
- Family history of CAD (first degree relative)
- Physician-diagnosed diabetes or stroke
- Overweight (BMI/=25) or obese (BMI>/=30)
- Total cholesterol >/=200, documented history of hypercholesterolemia, or currently taking lipid lowering medications
- History of smoking
- HDL </=44 mg/dl
- LDL >/=130 mg/dl or documented history of hyperlipidemia
- Elevated triglycerides (>/=200 mg/dl)
- Hypertension (systolic blood pressure >/=130 mmHg, diastolic blood pressure >/=85 mmHg, documented diagnosis of hypertension, or currently taking antihypertensive medications)
- Diabetes (fasting glucose >/=100 mg/dl, physician diagnosis of diabetes/pre-diabetes, or currently taking anti-glycemic medications)
- Post traumatic stress disorder (PTSD) or at risk for PTSD
- Insomnia (five hours of sleep per night or less) or sleep apnea
Exclusion Criteria:
- Age <18 years of age
- Unstable coronary syndromes, refractory congestive heart failure, uncontrolled arrhythmia, or high-grade uncorrected cardiac conduction abnormalities
- Any contraindication to components to Program, such as physical disabilities precluding stretching and aerobic exercise or medical conditions that preclude consumption of foods essential to Program diet
- Inability or unwillingness to give consent
- Significant left main stenosis (>50%) or ejection fraction <35% with no revascularization
- History of substance abuse (including alcohol) without self-certification of abstinence for at least three months
- Non-ambulatory (bedridden) individuals
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Lifestyle modification
The intervention group participated in individualized therapeutic lifestyle plans to reduce cardiovascular risk.
Participants were introduced to factors contributing to cardiovascular disease and met individually with a registered dietitian, exercise physiologist, stress management instructor, and psychologist to learn effective strategies for integrating healthy changes into their current lifestyle.
|
Intervention group enrolled in lifestyle program in which they developed individualized therapeutic lifestyle plans to reduce cardiovascular risk.
|
NO_INTERVENTION: Usual care controls
Control group received standard care from their primary physicians, but did not participate in any component of the lifestyle program or receive any information, advice, or counseling regarding healthy lifestyle behaviors.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Body Mass Index
Time Frame: Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years
|
Change in BMI
|
Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood Pressure
Time Frame: Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years
|
Change in systolic and diastolic BP
|
Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years
|
Blood Lipids
Time Frame: Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years
|
Change in HDL, LDL, total cholesterol, and triglycerides
|
Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Exercise Capacity
Time Frame: Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years
|
Change in exercise capacity defined by Bruce score on an exercise treadmill test
|
Baseline, 4-6 months, 1 year, 18 months, 2 years, 30 months, 3 years
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 08-07
- W81XWH-10-2-0080 (OTHER_GRANT: US Department of Defense)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaRecruitingCoronary Stenosis | Coronary Artery Bypass Grafting | Coronary Artery Disease Progression | Percutaneous Coronary RevascularizationKorea, Republic of
Clinical Trials on CRC lifestyle modification program
-
Instituto de Investigación Sanitaria AragónCompleted
-
Chinese University of Hong KongPrince of Wales Hospital, Shatin, Hong KongCompletedDiabetes Mellitus | Diabetes | Childhood Obesity | Gestational DiabetesHong Kong
-
Chinese University of Hong KongWithdrawn
-
Laval UniversityCompletedDiet, Healthy | Lifestyle-related Condition | Cardiometabolic Syndrome | Obesity, Visceral
-
Chinese University of Hong KongCompletedGestational Diabetes MellitusChina
-
Children's Hospital of PhiladelphiaUniversity of Pennsylvania; Geisinger Clinic; Pennsylvania Department of HealthCompleted
-
Unity Health TorontoUniversity Health Network, Toronto; St. Joseph's Health Centre TorontoUnknown
-
Riphah International UniversityRecruitingDiabetic NeuropathiesPakistan
-
Alberta Hip and Knee ClinicUniversity of CalgaryNot yet recruitingObesity | Osteo Arthritis Knee | Osteoarthritis, Hip
-
Chinese University of Hong KongCompletedType 2 Diabetes Mellitus | Type2 Diabetes | ObeseHong Kong